Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PAN-301-1 |
Trade Name | |
Synonyms | SNS-301|SNS301|SNS 301|PAN 301-1 |
Drug Descriptions |
PAN-301-1 is a vaccine targeting the human aspartyl/aspartate beta-hydroxylase (HAAH/ASPH) that triggers immune activity against tumor cells overexpressing HAAH (Journal of Clinical Oncology 36, no. 15_suppl, PMID: 32811566). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C148522 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PAN-301-1 | PAN-301-1 | 0 | 1 |
PAN-301-1 + Pembrolizumab | PAN-301-1 Pembrolizumab | 0 | 1 |